Elliott J, Bryant C E, Soydan J
Department of Veterinary Basic Sciences, Royal Veterinary College, London, UK.
Equine Vet J. 1994 Sep;26(5):378-84. doi: 10.1111/j.2042-3306.1994.tb04407.x.
Isolated equine digital veins were examined in vitro to study the importance of the endothelium in the responses to both vasodilator and vasoconstrictor agents and to characterise the endothelial-derived mediators involved. Carbachol (Cch; 1 microM) and bradykinin (Bk; 1 nM) caused relaxation of U44069-induced tone by 79.5 +/- 0.35% and 73.7 +/- 4.0% respectively. Mechanical removal of the endothelium completely prevented relaxant responses to Cch and to Bk showing they were mediated by the endothelium. Treatment of veins with NG-nitro-L-arginine methyl ester (L-NAME; 30 and 300 microM) inhibited vasorelaxant responses to both Cch and Bk whereas the cyclooxygenase inhibitor, ibuprofen (10 microM) had no inhibitory effect. The inhibitory action of L-NAME on the relaxations produced by Cch was partly reversed by L-arginine (3 and 10 mM). Cch-relaxations were potentiated in the presence of super oxide dismutase (15 units/ml) and inhibited by methylene blue (10 microM). The vasorelaxant effects of ATP (0.01 microM to 0.1 mM) were not dependent on the presence of the endothelium and the selective P2y receptor agonist, 2-methylthio-ATP proved to be ineffective as a vasodilator. Removal of the endothelium did not enhance the vasoconstrictor effects of the alpha 1 adrenoceptor agonist phenylephrine (0.01 microM to 0.1 mM) and treatment with L-NAME (300 microM) did not change the vasoconstrictor responses to 5-HT (1 nM to 10 microM) or the alpha 2 adrenoceptor agonist BHT-920 (1 nM to 1 microM).(ABSTRACT TRUNCATED AT 250 WORDS)
对离体马趾静脉进行体外研究,以探讨内皮细胞在对血管舒张剂和血管收缩剂反应中的重要性,并确定所涉及的内皮衍生介质的特征。卡巴胆碱(Cch;1微摩尔)和缓激肽(Bk;1纳摩尔)分别使U44069诱导的张力松弛79.5±0.35%和73.7±4.0%。机械去除内皮细胞完全消除了对Cch和Bk的松弛反应,表明这些反应是由内皮细胞介导的。用NG-硝基-L-精氨酸甲酯(L-NAME;30和300微摩尔)处理静脉可抑制对Cch和Bk的血管舒张反应,而环氧化酶抑制剂布洛芬(10微摩尔)则无抑制作用。L-NAME对Cch产生的松弛反应的抑制作用可被L-精氨酸(3和10毫摩尔)部分逆转。在超氧化物歧化酶(15单位/毫升)存在下,Cch诱导的松弛作用增强,而被亚甲蓝(10微摩尔)抑制。ATP(0.01微摩尔至0.1毫摩尔)的血管舒张作用不依赖于内皮细胞的存在,选择性P2y受体激动剂2-甲硫基-ATP作为血管舒张剂无效。去除内皮细胞不会增强α1肾上腺素能受体激动剂去氧肾上腺素(0.01微摩尔至0.1毫摩尔)的血管收缩作用,用L-NAME(300微摩尔)处理也不会改变对5-羟色胺(1纳摩尔至10微摩尔)或α2肾上腺素能受体激动剂BHT-920(1纳摩尔至1微摩尔)的血管收缩反应。(摘要截短于250字)